Magnet Recognized 🌟 UPMC Eases Nursing Burden.
See Study
→
877-349-4582
Request A Demo
Search
Solutions
EndoTool Glucose Management System
EndoTool IV
EndoTool SubQ
Interoperability
Analytics
Professional Services
Why it Matters
Evidence
About
Company Overview
Leadership Team
Clinical Advisory Board
Newsroom
Partnerships
Careers
Resources
Blog
Contact
877-349-4582
Request A Demo
877-349-4582
Request A Demo
Blog
Continuous Glucose Monitoring
,
Diabetes
,
Glycemic Management
,
Hyperglycemia
,
Insulin
,
Wearable Technology
/
The Game-Changing Approval of the First Over-The-Counter Continuous Glucose Monitor
This week, the FDA cleared the first over-the-counter-integrated continuous glucose monitor (iCGM) for marketing. This particular iCGM glucose biosensor is designed to help adult patients who are not on insulin, monitor their blood glucose levels in a noninvasive way. This particular iCGM glucose biosensor is meant for patients with or without diabetes to better understand the impact of diet and...
Continuous Glucose Monitoring
Diabetes
Glycemic Management
Hyperglycemia
Insulin
Wearable Technology
Search
Submit
Clear
Tags
A1C
ADA
CMS
Computerized Dosing
Conferences
Continuous Glucose Monitoring
Cost Savings
COVID-19
Diabetes
DKA
EMR Integration
EndoTool
Gestational Diabetes
Glycemic Management
Glycemic Steering Committee
Guidelines and Standards
Heart Failure
Hyperglycemia
Hypoglycemia
Hypothermia
Insulin
IV Insulin Dosing
Nursing
Obstetrics
Patient Safety
Performance Improvement
Personalized Dosing
Pharmacy
Renal Failure
Residual Insulin
Society of Hospital Medicine
SubQ Insulin Dosing
Surgical Site Infection
The Joint Commission
Transition IV to SubQ
Trauma
Wearable Technology
Workflow
Search
Submit
Clear
Client Login
Search
Submit
Clear
Solutions
EndoTool Glucose Management System
EndoTool IV
EndoTool SubQ
Interoperability
Analytics
Professional Services
Why it Matters
Evidence
About
Company Overview
Leadership Team
Clinical Advisory Board
Newsroom
Partnerships
Careers
Resources
Blog
Contact
Case Study
Discover UPMC Central Pennsylvania's approach to a 92% reduction in hypoglycemia.
Download Case Study
Scroll Up